GB0328796D0 - Compounds which interact with the G-protein coupled receptor family - Google Patents

Compounds which interact with the G-protein coupled receptor family

Info

Publication number
GB0328796D0
GB0328796D0 GBGB0328796.8A GB0328796A GB0328796D0 GB 0328796 D0 GB0328796 D0 GB 0328796D0 GB 0328796 A GB0328796 A GB 0328796A GB 0328796 D0 GB0328796 D0 GB 0328796D0
Authority
GB
United Kingdom
Prior art keywords
interact
compounds
coupled receptor
protein coupled
receptor family
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0328796.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOFOCUS PLC
Original Assignee
BIOFOCUS PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOFOCUS PLC filed Critical BIOFOCUS PLC
Priority to GBGB0328796.8A priority Critical patent/GB0328796D0/en
Publication of GB0328796D0 publication Critical patent/GB0328796D0/en
Priority to PCT/GB2004/005169 priority patent/WO2005056532A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
GBGB0328796.8A 2003-12-12 2003-12-12 Compounds which interact with the G-protein coupled receptor family Ceased GB0328796D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0328796.8A GB0328796D0 (en) 2003-12-12 2003-12-12 Compounds which interact with the G-protein coupled receptor family
PCT/GB2004/005169 WO2005056532A1 (en) 2003-12-12 2004-12-10 Indazole derivatives which interact with the g-protein coupled receptor family

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0328796.8A GB0328796D0 (en) 2003-12-12 2003-12-12 Compounds which interact with the G-protein coupled receptor family

Publications (1)

Publication Number Publication Date
GB0328796D0 true GB0328796D0 (en) 2004-01-14

Family

ID=30130085

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0328796.8A Ceased GB0328796D0 (en) 2003-12-12 2003-12-12 Compounds which interact with the G-protein coupled receptor family

Country Status (2)

Country Link
GB (1) GB0328796D0 (en)
WO (1) WO2005056532A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8106070B2 (en) 2006-10-20 2012-01-31 Merck Sharp & Dohme Corp. Substituted imidazoles as bombesin receptor subtype-3 modulators
EP2091937A2 (en) 2006-10-20 2009-08-26 Merck & Co., Inc. Substituted imidazoles as bombesin receptor subtype-3 modulators
EP2083623A1 (en) 2006-10-20 2009-08-05 Merck & Co., Inc. Substituted imidazoles as bombesin receptor subtype-3 modulators
KR100832747B1 (en) 2006-10-27 2008-05-27 한국화학연구원 Aminopyrazole derivatives, process for the preparation thereof, and composition for preventing or treating an ischemic disease containing the same
US7858645B2 (en) * 2006-11-01 2010-12-28 Hoffmann-La Roche Inc. Indazole derivatives
EP2102201B1 (en) * 2006-12-11 2010-10-13 Merck Sharp & Dohme Corp. Substituted diazepine sulfonamides as bombesin receptor subtype-3 modulators
US20110038850A1 (en) * 2007-01-05 2011-02-17 Didier Bagnol G Protein-Coupled Receptor and Modulators Thereof For The Treatment of Gaba-Related Neurological Disorders Including Sleep-Related Disorders
KR20100015499A (en) * 2007-04-13 2010-02-12 노파르티스 아게 Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonists
HUE040489T2 (en) 2014-06-03 2019-03-28 Idorsia Pharmaceuticals Ltd Pyrazole compounds and their use as t-type calcium channel blockers
EA032873B1 (en) 2014-09-15 2019-07-31 Идорсиа Фармасьютиклз Лтд Triazole compounds as t-type calcium channel blockers
MA49114A (en) 2016-12-16 2020-03-25 Idorsia Pharmaceuticals Ltd PHARMACEUTICAL COMBINATION INCLUDING A T-TYPE CALCIUM CHANNEL BLOCKER
EP3577099B1 (en) 2017-02-06 2024-01-24 Idorsia Pharmaceuticals Ltd A novel process for the synthesis of 1-aryl-1-trifluoromethylcyclopropanes
CN111205227A (en) * 2018-11-22 2020-05-29 四川大学 3-vinyl indazole derivative and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725431A (en) * 1970-09-23 1973-04-03 Ciba Geigy Corp 1-aralkyl-3-aminoindazoles
EP1501800A1 (en) * 2002-05-03 2005-02-02 Warner-Lambert Company LLC Bombesin antagonists
DE10224844A1 (en) * 2002-06-05 2004-01-08 Solvay Pharmaceuticals Gmbh Non-peptide BRS-3 agonists

Also Published As

Publication number Publication date
WO2005056532A1 (en) 2005-06-23

Similar Documents

Publication Publication Date Title
GB0509275D0 (en) Synthetic receptor
IL190094A0 (en) Amino-alkyl-amide derivatives as ccr3 receptor liquids
GB0328796D0 (en) Compounds which interact with the G-protein coupled receptor family
GB0509276D0 (en) Synthetic receptor
EP1631559A4 (en) Il-8 receptor antagonists
GB0403578D0 (en) Compounds which interact with the G-protein coupled receptor family
EP1701948A4 (en) Assay for entactogens
IL173337A0 (en) Receptor
EP1991911A4 (en) Plasticized photoconductor
IL174197A0 (en) Chimeric gabab receptor
GB2420624B (en) Sonde attachment means
GB0306522D0 (en) Fastening mechanism
PL370290A1 (en) Polyolephin based thermoplastics compound
GB0414798D0 (en) Receptor
GB0504066D0 (en) Compounds which interact with the g-protein coupled receptor family
GB0516946D0 (en) Receptor
GB0321998D0 (en) Receptor
GB0425739D0 (en) Humanised baculovirus 2
GB0510138D0 (en) Novel compounds A4
GB0413872D0 (en) Receptor
GB0307100D0 (en) Receptor
GB0329104D0 (en) Receptor
GB0317346D0 (en) 5-ht2b receptor antagonists
GB0320275D0 (en) Skill-ball mechanism
EP1701949A4 (en) Assay for entactogens

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)